Overview

A Long-term Study for the Treatment of Painful Diabetic Neuropathy

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate safety and efficacy of duloxetine for patients with painful diabetic neuropathy at long-term use.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Shionogi
Treatments:
Duloxetine Hydrochloride